| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | extracellular matrix | 5.47e-04 | 656 | 60 | 8 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.58e-04 | 658 | 60 | 8 | GO:0030312 | |
| MousePheno | abnormal vascular wound healing | 3.51e-06 | 73 | 45 | 5 | MP:0004883 | |
| Domain | NBPF_dom | 2.19e-08 | 11 | 55 | 4 | IPR010630 | |
| Domain | NBPF | 2.19e-08 | 11 | 55 | 4 | PS51316 | |
| Domain | DUF1220 | 2.19e-08 | 11 | 55 | 4 | PF06758 | |
| Domain | DUF1220 | 2.00e-06 | 9 | 55 | 3 | SM01148 | |
| Domain | Thbs/COMP_coiled-coil | 2.55e-05 | 3 | 55 | 2 | IPR024665 | |
| Domain | COMP | 2.55e-05 | 3 | 55 | 2 | PF11598 | |
| Domain | TSP_3 | 8.47e-05 | 5 | 55 | 2 | PF02412 | |
| Domain | TSP3 | 8.47e-05 | 5 | 55 | 2 | PS51234 | |
| Domain | TSP_CTER | 8.47e-05 | 5 | 55 | 2 | PS51236 | |
| Domain | - | 8.47e-05 | 5 | 55 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 8.47e-05 | 5 | 55 | 2 | IPR008859 | |
| Domain | TSP_C | 8.47e-05 | 5 | 55 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 8.47e-05 | 5 | 55 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 8.47e-05 | 5 | 55 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 8.47e-05 | 5 | 55 | 2 | IPR028974 | |
| Domain | Growth_fac_rcpt_ | 9.47e-05 | 156 | 55 | 5 | IPR009030 | |
| Domain | ConA-like_dom | 4.57e-04 | 219 | 55 | 5 | IPR013320 | |
| Domain | PLAC | 1.41e-03 | 19 | 55 | 2 | PS50900 | |
| Domain | PLAC | 1.41e-03 | 19 | 55 | 2 | IPR010909 | |
| Domain | IG | 1.44e-03 | 421 | 55 | 6 | SM00409 | |
| Domain | Ig_sub | 1.44e-03 | 421 | 55 | 6 | IPR003599 | |
| Domain | ADAM_spacer1 | 2.07e-03 | 23 | 55 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.07e-03 | 23 | 55 | 2 | PF05986 | |
| Domain | EGF_CA | 2.08e-03 | 86 | 55 | 3 | PF07645 | |
| Domain | - | 2.76e-03 | 95 | 55 | 3 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 2.93e-03 | 97 | 55 | 3 | IPR018097 | |
| Domain | EGF_CA | 3.10e-03 | 99 | 55 | 3 | PS01187 | |
| Domain | IG_LIKE | 3.12e-03 | 491 | 55 | 6 | PS50835 | |
| Domain | Ig-like_dom | 3.51e-03 | 503 | 55 | 6 | IPR007110 | |
| Domain | Cadherin | 4.50e-03 | 113 | 55 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 4.61e-03 | 114 | 55 | 3 | PS50268 | |
| Domain | - | 4.61e-03 | 114 | 55 | 3 | 2.60.40.60 | |
| Domain | CA | 4.73e-03 | 115 | 55 | 3 | SM00112 | |
| Domain | Cadherin-like | 4.84e-03 | 116 | 55 | 3 | IPR015919 | |
| Domain | Cadherin | 5.08e-03 | 118 | 55 | 3 | IPR002126 | |
| Domain | EGF_CA | 5.57e-03 | 122 | 55 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.83e-03 | 124 | 55 | 3 | IPR001881 | |
| Domain | EGF-like_dom | 6.18e-03 | 249 | 55 | 4 | IPR000742 | |
| Domain | C2-set_2 | 6.49e-03 | 41 | 55 | 2 | PF08205 | |
| Domain | CD80_C2-set | 6.49e-03 | 41 | 55 | 2 | IPR013162 | |
| Domain | EGF_1 | 6.71e-03 | 255 | 55 | 4 | PS00022 | |
| Domain | PRY | 6.80e-03 | 42 | 55 | 2 | PF13765 | |
| Domain | EGF-like_CS | 7.27e-03 | 261 | 55 | 4 | IPR013032 | |
| Domain | EGF_2 | 7.67e-03 | 265 | 55 | 4 | PS01186 | |
| Domain | PRY | 8.81e-03 | 48 | 55 | 2 | SM00589 | |
| Domain | PRY | 8.81e-03 | 48 | 55 | 2 | IPR006574 | |
| Pubmed | 2.45e-20 | 21 | 61 | 9 | 16079250 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 3.51e-12 | 10 | 61 | 5 | 22973535 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 2.06e-08 | 170 | 61 | 7 | 23314748 | |
| Pubmed | 2.71e-07 | 513 | 61 | 9 | 25798074 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7700633 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 30785396 | ||
| Pubmed | Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration. | 3.03e-06 | 2 | 61 | 2 | 38528617 | |
| Pubmed | The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase. | 3.03e-06 | 2 | 61 | 2 | 25742604 | |
| Pubmed | Upregulation of ADAMTS‑7 and downregulation of COMP are associated with aortic aneurysm. | 3.03e-06 | 2 | 61 | 2 | 28849199 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10354554 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16585064 | ||
| Pubmed | Upregulation of ADAMTS‑7 and downregulation of COMP are associated with spontaneous abortion. | 3.03e-06 | 2 | 61 | 2 | 30720083 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 31323021 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DGCR2 DNAJC14 ADAMTS7 CTC1 KCNG1 LAMA5 IRS1 PRAG1 DUS1L NBPF1 WDR24 | 3.09e-06 | 1105 | 61 | 11 | 35748872 |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12458213 | ||
| Pubmed | Pathological Significance and Prognostic Roles of Thrombospondin-3, 4 and 5 in Bladder Cancer. | 9.07e-06 | 3 | 61 | 2 | 33910854 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 28072873 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 25712208 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.03e-05 | 430 | 61 | 7 | 35044719 | |
| Pubmed | 1.46e-05 | 27 | 61 | 3 | 20490451 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 16364318 | ||
| Pubmed | No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. | 1.81e-05 | 4 | 61 | 2 | 18615538 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 18485748 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 17051426 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 23708119 | ||
| Pubmed | Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer. | 1.81e-05 | 4 | 61 | 2 | 15247132 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 23169578 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 18398029 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 30622267 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 7798939 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 16030120 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 30352047 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 18467703 | ||
| Pubmed | IGF1, growth pathway polymorphisms and schizophrenia: a pooling study. | 3.02e-05 | 5 | 61 | 2 | 17044098 | |
| Pubmed | Chibby interacts with NBPF1 and clusterin, two candidate tumor suppressors linked to neuroblastoma. | 3.02e-05 | 5 | 61 | 2 | 20096688 | |
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 29101209 | ||
| Pubmed | BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. | 4.52e-05 | 6 | 61 | 2 | 20208008 | |
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 16448675 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 16489531 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 26853750 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 21521316 | ||
| Pubmed | Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. | 6.32e-05 | 7 | 61 | 2 | 18059035 | |
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 16286467 | ||
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 25014791 | ||
| Pubmed | 6.32e-05 | 7 | 61 | 2 | 20540360 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 6.32e-05 | 7 | 61 | 2 | 11170752 | |
| Pubmed | 6.46e-05 | 44 | 61 | 3 | 21308778 | ||
| Pubmed | 8.42e-05 | 8 | 61 | 2 | 19734900 | ||
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 8.42e-05 | 8 | 61 | 2 | 24460873 | |
| Pubmed | A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. | 1.08e-04 | 9 | 61 | 2 | 25362351 | |
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 31199918 | ||
| Pubmed | 1.29e-04 | 146 | 61 | 4 | 27068509 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 19082521 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 16081822 | ||
| Pubmed | Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer. | 1.35e-04 | 10 | 61 | 2 | 20416304 | |
| Pubmed | Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. | 1.35e-04 | 10 | 61 | 2 | 19124510 | |
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 20509872 | ||
| Pubmed | Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. | 1.35e-04 | 10 | 61 | 2 | 21852217 | |
| Pubmed | Genetic mapping of the tumor-associated mucin 1 gene on mouse chromosome 3. | 1.35e-04 | 10 | 61 | 2 | 7626896 | |
| Pubmed | Common type 2 diabetes risk gene variants associate with gestational diabetes. | 2.33e-04 | 13 | 61 | 2 | 18984664 | |
| Pubmed | Lineage-specific gene duplication and loss in human and great ape evolution. | 2.48e-04 | 69 | 61 | 3 | 15252450 | |
| Pubmed | Class III myosins shape the auditory hair bundles by limiting microvilli and stereocilia growth. | 2.72e-04 | 14 | 61 | 2 | 26754646 | |
| Pubmed | 2.72e-04 | 14 | 61 | 2 | 9151674 | ||
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 3.13e-04 | 15 | 61 | 2 | 18855897 | |
| Pubmed | 3.13e-04 | 15 | 61 | 2 | 17339472 | ||
| Pubmed | 3.17e-04 | 75 | 61 | 3 | 20571754 | ||
| Pubmed | 3.57e-04 | 16 | 61 | 2 | 37683603 | ||
| Pubmed | 3.57e-04 | 16 | 61 | 2 | 35140200 | ||
| Pubmed | 4.05e-04 | 17 | 61 | 2 | 23754948 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 4.55e-04 | 18 | 61 | 2 | 9149941 | |
| Pubmed | 5.08e-04 | 19 | 61 | 2 | 16705022 | ||
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | 5.08e-04 | 374 | 61 | 5 | 19625176 | |
| Pubmed | 5.53e-04 | 381 | 61 | 5 | 18676680 | ||
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | 5.59e-04 | 382 | 61 | 5 | 19170196 | |
| Pubmed | 5.66e-04 | 383 | 61 | 5 | 19453261 | ||
| Pubmed | 6.22e-04 | 21 | 61 | 2 | 18591388 | ||
| Pubmed | Underlying genetic models of inheritance in established type 2 diabetes associations. | 6.22e-04 | 21 | 61 | 2 | 19602701 | |
| Pubmed | 6.22e-04 | 21 | 61 | 2 | 25340332 | ||
| Pubmed | 6.83e-04 | 22 | 61 | 2 | 25147951 | ||
| Pubmed | 6.83e-04 | 22 | 61 | 2 | 25587709 | ||
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 7.12e-04 | 229 | 61 | 4 | 19948975 | |
| Pubmed | 7.48e-04 | 23 | 61 | 2 | 19720844 | ||
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 8.65e-04 | 421 | 61 | 5 | 19692168 | |
| Pubmed | 8.84e-04 | 25 | 61 | 2 | 18992263 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 9.57e-04 | 248 | 61 | 4 | 24006456 | |
| Pubmed | 1.03e-03 | 27 | 61 | 2 | 20384434 | ||
| Pubmed | 1.11e-03 | 28 | 61 | 2 | 20301750 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 1.15e-03 | 1201 | 61 | 8 | 35696571 | |
| Pubmed | Obesity and diabetes genetic variants associated with gestational weight gain. | 1.19e-03 | 29 | 61 | 2 | 20816152 | |
| Pubmed | 1.28e-03 | 30 | 61 | 2 | 9405660 | ||
| Pubmed | 1.40e-03 | 125 | 61 | 3 | 19019335 | ||
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 1.45e-03 | 32 | 61 | 2 | 22424883 | |
| Pubmed | Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. | 1.50e-03 | 128 | 61 | 3 | 18818748 | |
| Pubmed | Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. | 1.50e-03 | 128 | 61 | 3 | 19527514 | |
| Pubmed | 1.54e-03 | 33 | 61 | 2 | 12414734 | ||
| Pubmed | Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. | 1.64e-03 | 34 | 61 | 2 | 20581827 | |
| Pubmed | 1.73e-03 | 35 | 61 | 2 | 18992148 | ||
| Interaction | NEK4 interactions | NBPF8 NBPF12 SH3PXD2A NBPF9 APC2 NBPF10 PCDHA12 NBPF11 NBPF14 NBPF1 | 8.95e-06 | 582 | 61 | 10 | int:NEK4 |
| Interaction | DIP2A interactions | 1.06e-05 | 96 | 61 | 5 | int:DIP2A | |
| Interaction | ADAM12 interactions | 2.85e-05 | 58 | 61 | 4 | int:ADAM12 | |
| Cytoband | 1q21.1 | 2.32e-08 | 62 | 62 | 5 | 1q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 7.49e-08 | 404 | 62 | 8 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p11 | 3.71e-04 | 21 | 62 | 2 | chr1p11 | |
| GeneFamily | Neuroblastoma breakpoint family | NBPF8 NBPF19 NBPF12 NBPF9 NBPF10 NBPF26 NBPF11 NBPF14 NBPF20 NBPF1 | 3.48e-21 | 23 | 45 | 10 | 662 |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 6.23e-04 | 15 | 45 | 2 | 458 | |
| GeneFamily | Cadherin related | 8.04e-04 | 17 | 45 | 2 | 24 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 1.61e-03 | 24 | 45 | 2 | 654 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 4.45e-03 | 40 | 45 | 2 | 592 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.48e-03 | 161 | 45 | 3 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 7.74e-03 | 163 | 45 | 3 | 590 | |
| GeneFamily | Immunoglobulin like domain containing | 1.22e-02 | 193 | 45 | 3 | 594 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.51e-06 | 191 | 61 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.39e-06 | 196 | 61 | 6 | M3008 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 7.14e-06 | 53 | 61 | 4 | M6303 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | THBS3 SPINT2 KLF13 MAP3K8 ZNF174 NBPF9 LAMA5 NBPF26 IL1R1 ADAMTSL4 NBPF20 | 1.12e-05 | 955 | 61 | 11 | M45680 |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 3.81e-05 | 162 | 61 | 5 | M8243 | |
| Coexpression | NABA_CORE_MATRISOME | 3.90e-05 | 270 | 61 | 6 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 4.32e-05 | 275 | 61 | 6 | M5884 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN | 9.64e-05 | 197 | 61 | 5 | M3465 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.01e-04 | 199 | 61 | 5 | M7451 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 2.57e-07 | 189 | 62 | 6 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 2.57e-07 | 189 | 62 | 6 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.75e-06 | 144 | 62 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.62e-06 | 167 | 62 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-06 | 174 | 62 | 5 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.80e-06 | 184 | 62 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.80e-06 | 184 | 62 | 5 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-06 | 192 | 62 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.08e-06 | 197 | 62 | 5 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | Endothelial_cells-Endothelial-A|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.49e-06 | 199 | 62 | 5 | 2a1424c61ddcd1fea9574f7a3ad1955387458130 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.70e-06 | 200 | 62 | 5 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.70e-06 | 200 | 62 | 5 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.70e-06 | 200 | 62 | 5 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.47e-05 | 155 | 62 | 4 | 84221a285277292f7225eb69508c887541abeed1 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.47e-05 | 155 | 62 | 4 | 5fabe24a784f0be46040ffc886eabd8d5ce78121 | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.14e-05 | 159 | 62 | 4 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 8.05e-05 | 164 | 62 | 4 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.46e-05 | 171 | 62 | 4 | 23b3120706bb9c20b9214fe3760c6d7a84f1e749 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-05 | 173 | 62 | 4 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 173 | 62 | 4 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-04 | 179 | 62 | 4 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 180 | 62 | 4 | b234668bf181522807470e396792e1b54890b719 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 1.18e-04 | 181 | 62 | 4 | a62115a8da486fc61225901c72b1ec70bcaf4c36 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.25e-04 | 184 | 62 | 4 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 187 | 62 | 4 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.36e-04 | 188 | 62 | 4 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 62 | 4 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 62 | 4 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 62 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 62 | 4 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 189 | 62 | 4 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 190 | 62 | 4 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | facs-Heart-LA-24m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 190 | 62 | 4 | 911b93c4c828ef2d867b91a5eced2dc12a1baf27 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.48e-04 | 192 | 62 | 4 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 193 | 62 | 4 | d0a5f212f8e8a13dbbe3e41df92548ef82eef70b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.51e-04 | 193 | 62 | 4 | b93f6af5999ad207fef5edc2bd900c7c6342f626 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 193 | 62 | 4 | cc355b2ed6510619cad969ae074126d7c8db784d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.51e-04 | 193 | 62 | 4 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | 855d6acfcf323868ba98b213f06186ad4793d4ed | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | dc531cf9089f2c956621d70d49a2b8219b4b45c1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | 29a7770bdbea6081a9ed64a997cd92a1cbf4af58 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 194 | 62 | 4 | ca051088f880154ae2fd3f0ab3cef5a8dba8c371 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 195 | 62 | 4 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 195 | 62 | 4 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-04 | 195 | 62 | 4 | b5ee368c97113432fc8fe742654cd538558f327c | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 196 | 62 | 4 | 99953fe0a40e242f6945150345fc0a08ed95f8f9 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.60e-04 | 196 | 62 | 4 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | COVID-mDC2|COVID / Condition, Cell_class and T cell subcluster | 1.60e-04 | 196 | 62 | 4 | bb13926bb664be917017edb0ce7f184abe31744b | |
| ToppCell | COVID-mDC2-|COVID / Condition, Cell_class and T cell subcluster | 1.60e-04 | 196 | 62 | 4 | 6d02a4c5c19be7e036150cf945585cf5a773bc87 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 196 | 62 | 4 | 5edffdc4c1ff35d9ee0e5c1bed0dc0c90b76ea00 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.63e-04 | 197 | 62 | 4 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | droplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 197 | 62 | 4 | 9654472f1d4c9a6caadf1ff61a84902d171e9eb4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | d9e196c8b4a6ede4733946dbdba3331534954beb | |
| ToppCell | droplet-Heart-HEART-1m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 197 | 62 | 4 | 1ec3c05a5d4163df2cf0d168e28a3f1d35364da2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-04 | 198 | 62 | 4 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | 21-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 1.66e-04 | 198 | 62 | 4 | e735d82e5151c98b5724c543f8ad633c8ed824d2 | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|normal_Lung / Location, Cell class and cell subclass | 1.66e-04 | 198 | 62 | 4 | 2a251d13c2488d15ca9b11e643c1d17d428b6ef0 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-04 | 198 | 62 | 4 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-04 | 198 | 62 | 4 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.66e-04 | 198 | 62 | 4 | 361f3062f73a0add16dd6fbe927698416515879f | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-04 | 198 | 62 | 4 | e6dad9dea8cbd368b1b127572212cc913b909ffe | |
| ToppCell | 21-Trachea-Epithelial-Basal_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.66e-04 | 198 | 62 | 4 | 6ed75b53030028be915a90c0bca4d12e471914a5 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-iMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.66e-04 | 198 | 62 | 4 | bf5806424be33790f78f1c160398046a8725e469 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.69e-04 | 199 | 62 | 4 | 523e01f6a0abd9820697572e042a381aae8932dc | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-04 | 199 | 62 | 4 | 0d0d5cb821db16514192ad536849a8a04e22e637 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-04 | 199 | 62 | 4 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 | |
| ToppCell | mLN-ILC-ILC|mLN / Region, Cell class and subclass | 1.69e-04 | 199 | 62 | 4 | ab09a06cdea2597e9fe4b4b304655e9de4d433f6 | |
| ToppCell | mLN-ILC|mLN / Region, Cell class and subclass | 1.69e-04 | 199 | 62 | 4 | d6c299312c747fb1b7c53644c53efc03a5fffe85 | |
| ToppCell | mLN-(3)_ILC|mLN / shred on region, Cell_type, and subtype | 1.69e-04 | 199 | 62 | 4 | 00e0e2a766dd9c4d0a65f53d88fa50df4b6a3d60 | |
| ToppCell | mLN-(3)_ILC-(30)_ILC|mLN / shred on region, Cell_type, and subtype | 1.69e-04 | 199 | 62 | 4 | 33ac6d77099076df01299be429f4ba96f2f34cc1 | |
| ToppCell | NS-moderate-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-04 | 199 | 62 | 4 | aa2b51940115c22768c0d7493b4b60d41df3f376 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-04 | 199 | 62 | 4 | dfd60380a29f99e187050933ee5252ec11c68a32 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.69e-04 | 199 | 62 | 4 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.73e-04 | 200 | 62 | 4 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.73e-04 | 200 | 62 | 4 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 200 | 62 | 4 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.73e-04 | 200 | 62 | 4 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.73e-04 | 200 | 62 | 4 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 1.73e-04 | 200 | 62 | 4 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.73e-04 | 200 | 62 | 4 | a1f5684fe3815642159dd201b7ecc39f09bee1e8 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 200 | 62 | 4 | 6a76c8e3d937a9c54eb81cab23b8a898f9600de1 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 200 | 62 | 4 | 8f179b5768fd504af6dd6f6749a0bed7b689e77f | |
| ToppCell | NS-critical-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.73e-04 | 200 | 62 | 4 | 047e00f31ca744f82d61cac0e4e66563381f214b | |
| ToppCell | critical-Epithelial-Secretory-diff|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.73e-04 | 200 | 62 | 4 | 407465404c5818bd2cd9d489bfbf29c3a55429d4 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-04 | 200 | 62 | 4 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | Sepsis-ICU-SEP-Myeloid-cDC2|ICU-SEP / Disease, condition lineage and cell class | 1.73e-04 | 200 | 62 | 4 | 09d5c3a3d2b42b15c769dc2bc14b6c0d5cc38f91 | |
| Drug | Pesticides | NBPF8 NBPF12 NBPF9 NBPF10 IRS1 ALB NBPF11 NBPF14 NBPF20 NBPF1 | 5.42e-12 | 150 | 59 | 10 | ctd:D010575 |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.20e-05 | 197 | 59 | 6 | 2702_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.23e-05 | 198 | 59 | 6 | 996_DN | |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.27e-05 | 199 | 59 | 6 | 3481_DN | |
| Drug | exenatide | 1.56e-05 | 19 | 59 | 3 | ctd:C074031 | |
| Drug | iodine | 1.82e-05 | 125 | 59 | 5 | CID000000807 | |
| Disease | hippocampus volume change measurement, age at assessment | 2.05e-05 | 29 | 54 | 3 | EFO_0008007, EFO_0021492 | |
| Disease | osteoporosis (is_marker_for) | 4.91e-05 | 6 | 54 | 2 | DOID:11476 (is_marker_for) | |
| Disease | obstructive jaundice (biomarker_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:13603 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (is_marker_for) | 2.03e-04 | 62 | 54 | 3 | DOID:1485 (is_marker_for) | |
| Disease | white matter hyperintensity measurement | 2.28e-04 | 302 | 54 | 5 | EFO_0005665 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.75e-04 | 171 | 54 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | biliary atresia (is_marker_for) | 2.95e-04 | 14 | 54 | 2 | DOID:13608 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 3.16e-04 | 72 | 54 | 3 | DOID:9744 (is_marker_for) | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 5.51e-04 | 19 | 54 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | end stage renal disease (implicated_via_orthology) | 6.12e-04 | 20 | 54 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | impotence (biomarker_via_orthology) | 7.42e-04 | 22 | 54 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 8.11e-04 | 23 | 54 | 2 | C1708353 | |
| Disease | Brain Diseases | 9.60e-04 | 25 | 54 | 2 | C0006111 | |
| Disease | serum alanine aminotransferase measurement | 9.96e-04 | 869 | 54 | 7 | EFO_0004735 | |
| Disease | methionine measurement | 1.04e-03 | 26 | 54 | 2 | EFO_0009771 | |
| Disease | Nephrotic Syndrome | 1.12e-03 | 27 | 54 | 2 | C0027726 | |
| Disease | Encephalopathies | 1.12e-03 | 27 | 54 | 2 | C0085584 | |
| Disease | TYPE 2 DIABETES MELLITUS | 1.21e-03 | 28 | 54 | 2 | 125853 | |
| Disease | pneumonia (is_marker_for) | 1.21e-03 | 28 | 54 | 2 | DOID:552 (is_marker_for) | |
| Disease | Type 2 diabetes mellitus | 1.21e-03 | 28 | 54 | 2 | cv:C0011860 | |
| Disease | hearing threshold measurement | 1.21e-03 | 28 | 54 | 2 | EFO_0007618 | |
| Disease | antipsychotic drug use measurement | 1.29e-03 | 29 | 54 | 2 | EFO_0007792 | |
| Disease | Myopathy | 1.38e-03 | 30 | 54 | 2 | C0026848 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CPEERLLAENPQSTP | 546 | Q99814 | |
| DDNPNLPRLVRPEVD | 131 | P02768 | |
| PEQPDPRALQCAAFN | 381 | Q6UY14 | |
| SVQRAEEPRDLPDNP | 361 | O00478 | |
| DNDPNRDEVPRAQLP | 396 | A8MYA2 | |
| LEPPRLQRFQCGELP | 1171 | Q2NKJ3 | |
| VPNEKDNCPLVRNPD | 321 | P49747 | |
| GVPDSRDNCRLVPNP | 476 | P49747 | |
| PEDRPLIVQFCANDP | 71 | Q6P1R4 | |
| QDPGPEPRLQFRAVC | 51 | Q9H9F9 | |
| IPRLICDPDPNCEIN | 206 | Q05D60 | |
| PEPQLRACELVQPNR | 1206 | Q8IWY9 | |
| RPDDQQRKCSEQPCP | 866 | Q9UKP4 | |
| RQRATPDAPPADLQD | 631 | Q6Y2X3 | |
| NFDDNPLLRPPVEIC | 726 | A4D1F6 | |
| IELPREPRPNEECLQ | 436 | P04035 | |
| QEVRLDCEADGQPPP | 3241 | Q8NDA2 | |
| EPQSTLCAEPPDLQR | 391 | O75325 | |
| CLNQRPPENPDTDKN | 516 | Q92598 | |
| EALNPPREDQPRCQS | 386 | P41279 | |
| RSPRPCLNIEDDPDI | 846 | Q32MH5 | |
| LRPQDEPRQGCQPED | 46 | Q9UIX4 | |
| RQDNSLPRPCPTEQL | 1066 | O15230 | |
| VRCPSQLQPAPREEE | 921 | P35568 | |
| EDQGPPCPRLSRELL | 1031 | Q3BBV0 | |
| PLEPRREVCELNPDC | 66 | P02818 | |
| AIDQDRNIQPPSDRP | 306 | Q96QU1 | |
| QPRPSRLDLDLPGCQ | 961 | O95996 | |
| RLDLDLPGCQAEPPA | 966 | O95996 | |
| PEDLEQTQQRPLCPR | 1211 | Q711Q0 | |
| CNRLNRAPQPDELPE | 306 | P08571 | |
| GTQPPQARCRPNADL | 126 | Q6NZY7 | |
| TEPLRPELRCNPGQF | 21 | P98153 | |
| LNQQAPAPAPAERRE | 71 | Q9Y2Y9 | |
| QRVPDNPERFDSQPC | 356 | Q8WVV5 | |
| ANEIDVRPCPLNPNE | 36 | P14778 | |
| LQLSREDCLNPPSEP | 776 | Q9UN75 | |
| GLRCQPSPDEARPLQ | 91 | P17936 | |
| DRVEIRCLADGNPPP | 266 | P43121 | |
| LRCLELQPQDRPPSR | 1486 | Q13233 | |
| PPCLAQEGRYPRLEN | 211 | A0A1W2PRP0 | |
| PEPRALLNNEEPSQL | 51 | Q6ZUX3 | |
| DQGPPCPRLSRELLE | 726 | Q3BBV2 | |
| DQGPPCPRLSRELLE | 761 | P0DPF3 | |
| EGEENQNPPCPRLSR | 851 | P0DPF3 | |
| QNPPCPRLSRELLDE | 856 | P0DPF3 | |
| DQGPPCPRLSRELLE | 761 | Q6P3W6 | |
| EGEEDQNPPCPRLSR | 851 | Q6P3W6 | |
| QNPPCPRLSRELLDE | 856 | Q6P3W6 | |
| GEEDQNPPCPRLSRE | 1096 | Q6P3W6 | |
| EEDQNPPCPRLSREL | 1341 | Q6P3W6 | |
| EDQNPPCPRLSRELL | 1586 | Q6P3W6 | |
| EDQGPPCPRLSRELL | 1736 | Q6P3W6 | |
| DQNPPCPRLSRELLD | 1831 | Q6P3W6 | |
| DQGPPCPRLSRELLE | 1981 | Q6P3W6 | |
| EGEEDQNPPCPRLSR | 2071 | Q6P3W6 | |
| QNPPCPRLSRELLDE | 2076 | Q6P3W6 | |
| GEEDQNPPCPRLSRE | 2316 | Q6P3W6 | |
| EEDQNPPCPRLSREL | 2561 | Q6P3W6 | |
| EEDQGPPCPRLSREL | 2711 | Q6P3W6 | |
| EDQNPPCPRLSRELL | 2806 | Q6P3W6 | |
| EDQGPPCPRLSRELL | 2956 | Q6P3W6 | |
| DQNPPCPRLSRELLD | 3051 | Q6P3W6 | |
| EGEEDQNPPCPRLSR | 3291 | Q6P3W6 | |
| QNPPCPRLSRELLDE | 3296 | Q6P3W6 | |
| GEEDQNPPCPRLSRE | 3536 | Q6P3W6 | |
| EEDQNPPCPRLNGVL | 3706 | Q6P3W6 | |
| DQGPPCPRLSRELLE | 761 | Q86T75 | |
| EDQGPPCPRLSRELL | 1031 | Q5TAG4 | |
| DQNPPCPRLSRELLA | 1126 | Q5TAG4 | |
| DQGPPCPRLSRELLE | 1276 | Q5TAG4 | |
| DQGPPCPRLSRELLE | 421 | Q5TI25 | |
| EGEEDQNPPCPRLSR | 511 | Q5TI25 | |
| QNPPCPRLSRELLDE | 516 | Q5TI25 | |
| GEEDQNPPCPRLSRE | 581 | A0A087WUL8 | |
| EEDQNPPCPRLSREL | 826 | A0A087WUL8 | |
| EDQNPPCPRLSRELL | 1071 | A0A087WUL8 | |
| EDQDPPCPRLSRELV | 1221 | A0A087WUL8 | |
| DQNPPCPRLSRELLD | 1316 | A0A087WUL8 | |
| DQDPPCPRLSRELVE | 1466 | A0A087WUL8 | |
| EGEEDQNPPCPRLSR | 1556 | A0A087WUL8 | |
| QNPPCPRLSRELLDE | 1561 | A0A087WUL8 | |
| GEEDQNPPCPRLSRE | 1801 | A0A087WUL8 | |
| EEDQNPPCPRLSREL | 2046 | A0A087WUL8 | |
| EEDQGPPCPRLSREL | 2196 | A0A087WUL8 | |
| EDQNPPCPRLSRELL | 2291 | A0A087WUL8 | |
| EDQGPPCPRLSRELL | 2441 | A0A087WUL8 | |
| DQNPPCPRLSRELLD | 2536 | A0A087WUL8 | |
| DQGPPCPRLSRELLE | 2686 | A0A087WUL8 | |
| EGEEDQNPPCPRLSR | 2776 | A0A087WUL8 | |
| QNPPCPRLSRELLDE | 2781 | A0A087WUL8 | |
| GEEDQNPPCPRLSRE | 3021 | A0A087WUL8 | |
| EEDQNPPCPRLSREL | 3266 | A0A087WUL8 | |
| EEDQGPPCPRLSREL | 3416 | A0A087WUL8 | |
| EDQNPPCPRLSRELL | 3511 | A0A087WUL8 | |
| EDQGPPCPRLSRELL | 3661 | A0A087WUL8 | |
| DQGPPCPRLSRELLE | 146 | P0DPF2 | |
| EGEEDQNPPCPRLSR | 236 | P0DPF2 | |
| QNPPCPRLSRELLDE | 241 | P0DPF2 | |
| GEEDQNPPCPRLSRE | 481 | P0DPF2 | |
| EEDQNPPCPRLSREL | 726 | P0DPF2 | |
| EEDQGPPCPRLSREL | 876 | P0DPF2 | |
| EDQNPPCPRLSRELL | 971 | P0DPF2 | |
| EDQGPPCPRLSRELL | 1121 | P0DPF2 | |
| DQNPPCPRLSRELLD | 1216 | P0DPF2 | |
| DQGPPCPRLSRELLE | 1366 | P0DPF2 | |
| GEEDQNPPCPRLSRE | 1701 | P0DPF2 | |
| EEDQNPPCPRLSREL | 1946 | P0DPF2 | |
| EEDQGPPCPRLSREL | 2096 | P0DPF2 | |
| EDQNPPCPRLSRELL | 2191 | P0DPF2 | |
| EDQGPPCPRLSRELL | 2341 | P0DPF2 | |
| DQNPPCPRLSRELLD | 2436 | P0DPF2 | |
| DQGPPCPRLSRELLE | 2586 | P0DPF2 | |
| EGEEDQNPPCPRLSR | 2676 | P0DPF2 | |
| QNPPCPRLSRELLDE | 2681 | P0DPF2 | |
| GEEDQNPPCPRLSRE | 2921 | P0DPF2 | |
| EEDQNPPCPRLSREL | 3166 | P0DPF2 | |
| EEDQGPPCPRLSREL | 3316 | P0DPF2 | |
| EDQNPPCPRLSRELL | 3411 | P0DPF2 | |
| EDQGPPCPRLSRELL | 3561 | P0DPF2 | |
| DQNPPCPRLSRELLD | 3656 | P0DPF2 | |
| DQGPPCPRLSRELLE | 3806 | P0DPF2 | |
| EGEEDQNPPCPRLSR | 3896 | P0DPF2 | |
| QNPPCPRLSRELLDE | 3901 | P0DPF2 | |
| EEDQNPPCPRLSREL | 4386 | P0DPF2 | |
| EEDQGPPCPRLSREL | 4461 | P0DPF2 | |
| EDQNPPCPRLSRELL | 4556 | P0DPF2 | |
| EDQGPPCPRLSRELL | 4631 | P0DPF2 | |
| EDQGPPCPRLSRELL | 4781 | P0DPF2 | |
| DQNPPCPRLSRELLD | 4876 | P0DPF2 | |
| DQGPPCPRLSRELLE | 5026 | P0DPF2 | |
| QEVEEDQNPPCPRLS | 341 | B4DH59 | |
| DQNPPCPRLSRELLD | 346 | B4DH59 | |
| DQGPPCPRLSRELLE | 721 | B4DH59 | |
| RDRADPQQLPEAVPA | 366 | P57071 | |
| ENPRTPCVQQDDPRA | 376 | Q9H2D6 | |
| ESLECPAELRPQVPQ | 366 | O43734 | |
| PVNKDQCPRERPEEL | 31 | Q8IWU4 | |
| QELPDFQPQTPRRDL | 156 | Q15697 | |
| PPPKDNNLSCALRRN | 986 | Q5TCZ1 | |
| LRCFRQQENPPLPLG | 181 | O43291 | |
| NEPPRLNASPAAREE | 566 | Q9UGU0 | |
| PLGNDCPEQDRLPQR | 26 | Q9Y5Z9 | |
| DNCPKVPNPLQTDRD | 576 | P49746 | |
| PPRPENCRLEDEGVN | 61 | Q86YV5 | |
| EETPLVDCNNAPLPR | 1036 | P07949 | |
| ELLQEPCGQRDSPPD | 411 | Q5SQS7 | |
| EDPECVLPQEAFPLR | 561 | Q96S15 | |
| NRDPARPEECNLIEG | 166 | Q6PFW1 | |
| LDNCQDLFLLDPPRP | 36 | Q8WTR7 |